Company Filing History:
2 out of 162 
1 out of 366 
Years Active: 1995-1998
Title: The Innovations of Eugene S. Patterson
Introduction
Eugene S. Patterson is a notable inventor based in Oklahoma City, OK. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic agents and treatments for thrombosis. With a total of 3 patents, Patterson's work has had a meaningful impact on medical science.
Latest Patents
Patterson's latest patents include innovative compounds and methods that address critical health issues. One of his patents focuses on N-alkyl and N-acyl derivatives of 3,7-Diazabicyclo-3.3.1 nonanes, which are disclosed as multiclass antiarrhythmic agents. Another significant patent involves a method and composition for the treatment of thrombosis in mammals. This composition comprises microcapsules suitable for parenteral injection, containing a plasminogen activator core surrounded by a semi-permeable biocompatible layer. This design allows for controlled release of the plasminogen activator, enhancing treatment efficacy.
Career Highlights
Throughout his career, Patterson has worked with reputable institutions such as Oklahoma State University and Research Corporation Technologies, Inc. His research has contributed to advancements in medical treatments, particularly in the areas of cardiovascular health and drug delivery systems.
Collaborations
Patterson has collaborated with notable professionals in his field, including Kenneth D. Berlin and Gregory Lynn Garrison. These collaborations have further enriched his research and development efforts.
Conclusion
Eugene S. Patterson's innovative work in pharmaceuticals showcases his dedication to improving medical treatments. His patents reflect a commitment to addressing significant health challenges through scientific research and collaboration.